Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues

被引:252
作者
Dusserre, E
Moulin, P
Vidal, H [1 ]
机构
[1] Fac Med RTH Leannec, INSERM, U449, F-69373 Lyon 08, France
[2] Fac Med RTH Leannec, GENEALYS, F-69373 Lyon, France
[3] Hop Antiquaille, Lab Metab Lipides, Lyon, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2000年 / 1500卷 / 01期
关键词
angiotensinogen; acylation stimulating protein; cholesterol ester transfer protein; phospholipid transfer protein; TNF alpha; leptin;
D O I
10.1016/S0925-4439(99)00091-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the difference in gene expression of six proteins secreted by adipocytes in paired biopsies from visceral and abdominal subcutaneous adipose tissue in nine individuals with various degrees of obesity. The mRNAs levels of leptin, TNF alpha, angiotensinogen, acylation stimulating protein(ASP), cholesterol ester transfer protein (CETP) and phospholipid transfer protein (PLTP) were quantified by RT-competitive PCR. ASP and angiotensinogen mRNA levels were higher in the visceral fat, whereas the mRNA levels of leptin and CETP were higher in the subcutaneous depot. TNFa mRNA expression was similar in the two sites. For angiotensinogen, the difference was more pronounced in the subjects with body mass index (BMI) lower than 30 kg/m(2) whereas for ASP, CETP and leptin, the difference was observed regardless the BMI of the subjects. PLTP mRNA levels in subcutaneous, but not in the visceral, adipose tissue were positively related to the BMI of the subjects. These results strongly suggest that visceral and subcutaneous adipocytes may have different properties in the production of bioactive molecules. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 36 条
[1]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[2]   INCREASED PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN IN OBESE SUBJECTS - A POSSIBLE MECHANISM FOR THE REDUCTION OF SERUM HDL CHOLESTEROL LEVELS IN OBESITY [J].
ARAI, T ;
YAMASHITA, S ;
HIRANO, KI ;
SAKAI, N ;
KOTANI, K ;
FUJIOKA, S ;
NOZAKI, S ;
KENO, Y ;
YAMANE, M ;
SHINOHARA, E ;
ISLAM, AHMW ;
ISHIGAMI, M ;
NAKAMURA, T ;
KAMEDATAKEMURA, K ;
TOKUNAGA, K ;
MATSUZAWA, Y .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (07) :1129-1136
[3]   Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells [J].
Aubert, J ;
Ailhaud, G ;
Negrel, R .
FEBS LETTERS, 1996, 397 (01) :117-121
[4]  
Auboeuf D, 1997, ANAL BIOCHEM, V245, P141, DOI 10.1006/abio.1996.9986
[5]   METABOLIC IMPLICATIONS OF BODY-FAT DISTRIBUTION [J].
BJORNTORP, P .
DIABETES CARE, 1991, 14 (12) :1132-1143
[6]   Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport [J].
Bruce, C ;
Chouinard, RA ;
Tall, AR .
ANNUAL REVIEW OF NUTRITION, 1998, 18 :297-330
[7]  
CHOY LN, 1992, J BIOL CHEM, V267, P12736
[8]   ADIPSIN/ACYLATION STIMULATING PROTEIN SYSTEM IN HUMAN ADIPOCYTES - REGULATION OF TRIACYLGLYCEROL SYNTHESIS [J].
CIANFLONE, K ;
RONCARI, DAK ;
MASLOWSKA, M ;
BALDO, A ;
FORDEN, J ;
SNIDERMAN, AD .
BIOCHEMISTRY, 1994, 33 (32) :9489-9495
[9]   DIFFERENTIATION OF PREADIPOSE CELLS - PARACRINE ROLE OF PROSTACYCLIN UPON STIMULATION OF ADIPOSE-CELLS BY ANGIOTENSIN-II [J].
DARIMONT, C ;
VASSAUX, G ;
AILHAUD, G ;
NEGREL, R .
ENDOCRINOLOGY, 1994, 135 (05) :2030-2036
[10]  
DESPRES JP, 1987, AM J PHYSIOL, V252, pE6454